Byron D Ford

This inventor holds 7 USPTO granted patents and 3 published patent applications. Top assignees: Morehouse School of Medicine, Universidad Central Del Caribe of Bayamon. Active years: 2010-2014.

USPTO Granted Patents = 7 (Patent Applications = 3)

% Patents Active = 14.3

Average Co-Inventor Count = 1.2

ph-index = 2

Forward Citations = 36(Granted Patents)

Company Filing History:

7 out of 116

Morehouse School of Medicine

patents

1 out of 1

Universidad Central Del Caribe of Bayamon

patent

where one patent can have more than one assignee

Years Active: 2010-2014

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8791067 - Method for treating malaria (2014-07-29),

2. 8785369 - Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration (2014-07-22),

3. 8748131 - Chimeric neuregulins and method of making and use thereof (2014-06-10),

4. 8530525 - Methods and compositions for protecting and treating neuroinjury (2013-09-10),

5. 8008249 - Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration (2011-08-30),

6. 7973007 - Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration (2011-07-05),

7. 7776817 - Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration (2010-08-17),

Title: Byron D. Ford: Innovator in Medical Treatments

Introduction

Byron D. Ford is a prominent inventor based in Atlanta, GA (US), known for his significant contributions to medical science. He holds 7 patents that focus on innovative methods for treating various health conditions, particularly those related to inflammatory disorders and pathogenic infections.

Latest Patents

Ford's latest patents include a method for treating malaria, which describes compositions and methods aimed at preventing or ameliorating tissue damage caused by inflammatory disorders or pathogenic infections. One aspect of this method involves administering a therapeutically effective amount of a neuregulin to a subject. Additionally, the composition may include active agents that either increase the expression or activity of a neuregulin or inhibit the expression or activity of CXCL10, STAT3, or HEME. Another notable patent focuses on the use of neuregulin for preventing and treating damage from acute assaults on vascular and neuronal tissue. This neuroprotein has shown promise in ameliorating damage caused by mechanical or chemical assaults to blood vessels and enhancing stem cell migration to brain injury sites.

Career Highlights

Throughout his career, Byron D. Ford has worked with esteemed institutions such as Morehouse School of Medicine and Universidad Central Del Caribe in Bayamon. His research has significantly advanced the understanding of treatments for complex medical conditions.

Collaborations

Ford has collaborated with notable professionals in his field, including Peter Andrew Ferchmin and Vesna Ana Eterovic. These partnerships have contributed to the development of innovative medical solutions.

Conclusion

Byron D. Ford's work exemplifies the impact of innovation in the medical field, particularly through his patents that address critical health challenges. His contributions continue to pave the way for advancements in treatment methodologies.